Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral methylene blue for treatment of extensive thermal burns
IRCT20241116063729N2Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylene blue in thermal injury (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Wound size reduction, Rate of re-epithelialization and 2 more. Started Jul 2025; status: completed.
02
Drugs
methylene blue
03
Conditions
thermal injury
Beyond the preview
Go deeper on IRCT20241116063729N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241116063729N2.